We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+2.24%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.51B
AUM Growth
-$82.4M
Cap. Flow
-$100M
Cap. Flow %
-4%
Top 10 Hldgs %
22.43%
Holding
1,530
New
76
Increased
658
Reduced
739
Closed
53

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$7.83M
2
DD icon
DuPont de Nemours
DD
+$6.5M
3
ABBV icon
AbbVie
ABBV
+$5.98M
4
CELG
Celgene Corp
CELG
+$3.68M
5
NFLX icon
Netflix
NFLX
+$3.26M

Sector Composition

Rank Sector Weight
1 Technology 26.5%
2 Healthcare 18.58%
3 Financials 10.77%
4 Communication Services 10.27%
5 Consumer Discretionary 9.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DCI icon
551
Donaldson
DCI
$10.8B
$765K 0.03%
16,973
+1,138
+7% +$54.5K
CHE icon
552
Chemed
CHE
$6.78B
$762K 0.03%
2,791
+647
+30% +$171K
JBLU icon
553
JetBlue
JBLU
$1.96B
$762K 0.03%
37,509
-731
-2% -$15.5K
NOK icon
554
Nokia
NOK
$50.8B
$762K 0.03%
139,378
-113,046
-45% -$610K
WRB icon
555
W.R. Berkley
WRB
$28B
$761K 0.03%
35,350
-3,186
-8% -$66.5K
WSO icon
556
Watsco Inc
WSO
$14.9B
$759K 0.03%
4,195
+436
+12% +$75.6K
PTLA
557
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$758K 0.03%
23,211
-2,239
-9% -$98.3K
EDU icon
558
New Oriental
EDU
$7.84B
$757K 0.03%
8,632
-830
-9% -$77.2K
BRO icon
559
Brown & Brown
BRO
$22.9B
$753K 0.03%
29,584
+1,526
+5% +$39.9K
FTV icon
560
Fortive
FTV
$19B
$752K 0.03%
15,376
-1,363
-8% -$64.9K
TROW icon
561
T. Rowe Price
TROW
$25B
$752K 0.03%
6,968
-1,152
-14% -$128K
LECO icon
562
Lincoln Electric
LECO
$13.8B
$749K 0.03%
8,331
+630
+8% +$58.7K
NGVT icon
563
Ingevity
NGVT
$2.55B
$748K 0.03%
10,149
+53
+0.5% +$3.96K
EXP icon
564
Eagle Materials
EXP
$6.6B
$745K 0.03%
7,234
+1,489
+26% +$161K
JBTM
565
JBT Marel
JBTM
$7.14B
$744K 0.03%
6,561
+1,909
+41% +$218K
MMS icon
566
Maximus
MMS
$3.14B
$742K 0.03%
11,124
+1,386
+14% +$94.2K
OSK icon
567
Oshkosh
OSK
$9.67B
$742K 0.03%
9,599
+490
+5% +$41.8K
ZBH icon
568
Zimmer Biomet
ZBH
$17.7B
$742K 0.03%
7,013
-195
-3% -$22.6K
LPX icon
569
Louisiana-Pacific
LPX
$5.2B
$738K 0.03%
25,647
+3,470
+16% +$99.5K
IART icon
570
Integra LifeSciences
IART
$1.54B
$735K 0.03%
13,275
+2,682
+25% +$141K
FFIN icon
571
First Financial Bankshares
FFIN
$4.97B
$733K 0.03%
31,646
+5,148
+19% +$121K
PRI icon
572
Primerica
PRI
$9.81B
$733K 0.03%
7,585
+773
+11% +$77.6K
ATR icon
573
AptarGroup
ATR
$8.45B
$732K 0.03%
8,144
+517
+7% +$45.6K
PH icon
574
Parker-Hannifin
PH
$125B
$732K 0.03%
4,282
-329
-7% -$62.3K
DNKN
575
DELISTED
Dunkin' Brands Group, Inc.
DNKN
$732K 0.03%
12,265
+1,001
+9% +$62.1K

Similar funds

Profund Advisors's Q1 2018 Portfolio in Review

As of Q1 2018, Profund Advisors held 1,530 positions worth $2.51B, down 3.2% from $2.59B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Profund Advisors withdrew a net $100M in Q1 2018, closing 53 positions and reducing 739 holdings. Its most notable exit was Bioverativ Inc. Common Stock, an estimated $2.76M position sold in full.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Profund Advisors opened a new position in Okta worth $1.55M.

  • Profund Advisors's largest Q1 2018 buy was Okta: 38,807 shares worth $1.55M.
  • Profund Advisors added most to Agilent Technologies in Q1 2018, an estimated $7.07M increase.
  • Profund Advisors's biggest Q1 2018 reduction was Amgen, cutting an estimated $7.83M.
  • Profund Advisors fully exited Bioverativ Inc. Common Stock in Q1 2018, selling an estimated $2.76M.
  • Profund Advisors's ten largest holdings make up 22% of its $2.51B portfolio in Q1 2018.
  • Profund Advisors opened 76 new positions and closed 53 in Q1 2018.
  • Profund Advisors's portfolio value fell 3.2% quarter-over-quarter to $2.51B.

Based on Profund Advisors's 13F filing for Q1 2018, filed 14 May 2018.